ASPEN PHARMACARE HOLDINGS LIMITED - Renewal of Cautionary Announcement - Discussions with MSD
APN 201306030006A
Renewal of Cautionary Announcement - Discussions with MSD
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
Renewal of Cautionary Announcement- Discussions with MSD
Shareholders are referred to the cautionary announcement released by
Aspen on 4 February 2013 (and subsequent renewals of this cautionary
announcement) in which shareholders were advised of discussions
between Aspen and MSD, known as Merck in the United States and Canada,
in respect of a possible transaction comprising the acquisition of an
active pharmaceutical ingredient facility situated primarily in the
Netherlands and a related portfolio of pharmaceutical finished dose
form products.
These discussions remain ongoing and may have a material effect on the
price of Aspen’s securities if successfully concluded and accordingly
shareholders are advised to continue exercising caution when dealing
in Aspen’s securities.
Durban
3 June 2013
Sponsor: Investec Bank Limited
Date: 03/06/2013 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
